Baak LM, Wagenaar N, van der Aa NE, Groenendaal F, et al. Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study. Lancet Neurol 2022;21:528-536.
PMID: 35568047